Health Disparities in Chronic Obstructive Pulmonary Disease

  • Miriam Siegel
  • Jerry A. Krishnan
  • Jamie Lamson-Sullivan
  • Scott Cerreta
  • David M. Mannino
Chapter
Part of the Respiratory Medicine book series (RM)

Abstract

Chronic obstructive pulmonary disease (COPD) is the third most common cause of death in the U.S. There are numerous forms of disparities in COPD. These range from the obvious disparities in prevalence and outcomes in different racial and ethnic groups to more subtle disparities such as how COPD is perceived by patients and the general public relative to other chronic diseases. In this review, we present the topic of disparities in COPD from a range of perspectives: definition, diagnosis, care, outcomes, policies, and public funding of research. Recent years have shown considerable movement in decreasing many of these disparities, although there remains a need for continued progress on many fronts.

Keywords

Chronic obstructive pulmonary disease (COPD) Race Ethnicity Gender Hospitalizations Death Funding 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

We gratefully acknowledge funding by the Patient-Centered Outcomes Research Institute (CE-1304-6490 and IH-12-11-4365; Krishnan)

Conflict of Interest Statement: DMM has served as a consultant for Boehringer Ingelheim, GlaxoSmithKline, Astra-Zeneca, Novartis, Merck and Forest and has received research grants from GlaxoSmithKline, Novartis, Boehringer-Ingelheim, Forest and Pfizer. MS, JK. JLS, and SC report no conflicts of interest.

References

  1. 1.
    CDC. Chronic obstructive pulmonary disease among adults—United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61(46):938–43.Google Scholar
  2. 2.
    Ford ES, Mannino DM, Zhao G, Li C, Croft JB. Changes in mortality among US adults with COPD in two national cohorts recruited from 1971-1975 and 1988-1994. Chest. 2012;141(1):101–10.CrossRefPubMedGoogle Scholar
  3. 3.
    Monteagudo M, Rodriguez-Blanco T, Parcet J, Penalver N, Rubio C, Ferrer M, et al. Variability in the performing of spirometry and its consequences in the treatment of COPD in primary care. Arch Bronconeumol. 2011;47(5):226–33.CrossRefPubMedGoogle Scholar
  4. 4.
    Joo MJ, Au DH, Fitzgibbon ML, McKell J, Lee TA. Determinants of spirometry use and accuracy of COPD diagnosis in primary care. J Gen Intern Med. 2011;26(11):1272–7.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Roche N, Dalmay F, Perez T, Kuntz C, Vergnenegre A, Neukirch F, et al. FEV1/FVC and FEV1 for the assessment of chronic airflow obstruction in prevalence studies: do prediction equations need revision? Respir Med. 2008;102(11):1568–74.CrossRefPubMedGoogle Scholar
  6. 6.
    Lamprecht B, Schirnhofer L, Kaiser B, Buist SA, Mannino DM, Studnicka M. Subjects with discordant airways obstruction: lost between spirometric definitions of COPD. Pulm Med. 2011;2011:780215.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Damarla M, Celli BR, Mullerova HX, Pinto-Plata VM. Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure. Respir Care. 2006;51(10):1120–4.PubMedGoogle Scholar
  8. 8.
    Miravitlles M, Soriano JB, Garcia-Rio F, Munoz L, Duran-Tauleria E, Sanchez G, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009;64(10):863–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest. 2001;119(6):1691–5.CrossRefPubMedGoogle Scholar
  10. 10.
    Miravitlles M, de la Roza C, Naberan K, Lamban M, Gobartt E, Martin A, et al. Attitudes toward the diagnosis of chronic obstructive pulmonary disease in primary care. Arch Bronconeumol. 2006;42(1):3–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Ford ES, Croft JB, Mannino D, Wheaton AG, Zhang X, Giles WH. COPD surveillance-United States, 1999-2011. Chest J. 2013;144(1):284–305.CrossRefGoogle Scholar
  12. 12.
    Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523–32.CrossRefPubMedGoogle Scholar
  13. 13.
    Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741–50.CrossRefPubMedGoogle Scholar
  14. 14.
    Ford ES, Mannino DM, Wheaton AG, Giles WH, Presley-Cantrell L, Croft JB. Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010. Chest. 2013;143(5):1395–406.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Forey BA, Thornton AJ, Lee PN. Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med. 2011;11:36.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Han MK, Postma D, Mannino DM, Giardino ND, Buist S, Curtis JL, et al. Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med. 2007;176(12):1179–84.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Foreman MG, Zhang L, Murphy J, Hansel NN, Make B, Hokanson JE, et al. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med. 2011;184(4):414–20.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Hansel NN, Washko GR, Foreman MG, Han MK, Hoffman EA, DeMeo DL, et al. Racial differences in CT phenotypes in COPD. COPD. 2013;10(1):20–7.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Menezes AM, Perez-Padilla R, Jardim JR, Muino A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366(9500):1875–81.CrossRefPubMedGoogle Scholar
  20. 20.
    Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–73.CrossRefPubMedGoogle Scholar
  21. 21.
    Kaplan A. Effect of tiotropium on quality of life in COPD: a systematic review. Prim Care Respir J. 2010;19(4):315–25.CrossRefPubMedGoogle Scholar
  22. 22.
    Celli B, Decramer M, Kesten S, Liu D, Mehra S, Tashkin DP, et al. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(10):948–55.CrossRefPubMedGoogle Scholar
  23. 23.
    Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15):1543–54.CrossRefPubMedGoogle Scholar
  24. 24.
    Blanc PD, Eisner MD, Yelin EH, Earnest G, Balmes JR, Gregorich SE, et al. Socioeconomic gradients in tiotropium use among adults with COPD. Int J Chron Obstruct Pulmon Dis. 2008;3(3):483–90.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Mamary AJ, Gaughan JP, Murphy J, Vance GB, Criner GJ, COPDGene Investigators. Disparities in COPD diagnosis and treatment are determined by region, race, gender and education. American Journal of Respiratory and Critical Care Medicine, Vol. 181, Meeting Abstracts; 2010.Google Scholar
  26. 26.
    Wille KM, Harrington KF, deAndrade JA, Vishin S, Oster RA, Kaslow RA. Disparities in lung transplantation before and after introduction of the lung allocation score. J Heart Lung Transplant. 2013;32(7):684–92.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Lederer DJ, Benn EK, Barr RG, Wilt JS, Reilly G, Sonett JR, et al. Racial differences in waiting list outcomes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177(4):450–4.CrossRefPubMedGoogle Scholar
  28. 28.
    de Oca MM, Tálamo C, Halbert RJ, Perez-Padilla R, Lopez MV, Muiño A, et al. Frequency of self-reported COPD exacerbation and airflow obstruction in five Latin American cities. The Proyecto Latinoamericano de Investigación en Obstrucción Pulmonar (PLATINO) Study. Chest J. 2009;136(1):71–8.CrossRefGoogle Scholar
  29. 29.
    Garcia-Aymerich J, Serra Pons I, Mannino DM, Maas AK, Miller DP, Davis KJ. Lung function impairment, COPD hospitalisations and subsequent mortality. Thorax. 2011;66(7):585–90.CrossRefPubMedGoogle Scholar
  30. 30.
    Elixhauser A, Au DH, Podulka J. Readmissions for chronic obstructive pulmonary disease, 2008: statistical brief #121. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs, Rockville; 2011.Google Scholar
  31. 31.
    Han MK, Curran-Everett D, Dransfield MT, Criner GJ, Zhang L, Murphy JR, et al. Racial differences in quality of life in patients with COPD. Chest. 2011;140(5):1169–76.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Eisner MD, Blanc PD, Omachi TA, Yelin EH, Sidney S, Katz PP, et al. Socioeconomic status, race and COPD health outcomes. J Epidemiol Community Health. 2011;65(1):26–34.CrossRefPubMedGoogle Scholar
  33. 33.
    Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest. 2002;121(5 Suppl):121S–6.CrossRefPubMedGoogle Scholar
  34. 34.
    Gillum LA, Gouveia C, Dorsey ER, Pletcher M, Mathers CD, McCulloch CE, et al. NIH disease funding levels and burden of disease. PLoS One. 2011;6(2), e16837.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD. 2010;7(1):32–43.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Arne M, Emtner M, Janson S, Wilde-Larsson B. COPD patients perspectives at the time of diagnosis: a qualitative study. Prim Care Respir J. 2007;16(4):215–21.CrossRefPubMedGoogle Scholar
  37. 37.
    US Department of Health and Human Services. The health consequences of smoking-50 years of progress: a report of the Surgeon General. Atlanta: US Department of Health and Human Services; 2014.Google Scholar
  38. 38.
    Centers for Disease Control and Prevention. Public health strategic framework for COPD prevention. Washington, DC: Centers for Disease Control and Prevention; 2011.Google Scholar
  39. 39.
    Najafzadeh M, Marra CA, Lynd LD, Sadatsafavi M, FitzGerald JM, McManus B, et al. Future impact of various interventions on the burden of COPD in Canada: a dynamic population model. PLoS One. 2012;7(10), e46746.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Chen Y, Breithaupt K, Muhajarine N. Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors. J Clin Epidemiol. 2000;53(7):755–61.CrossRefPubMedGoogle Scholar
  41. 41.
    Ferre A, Fuhrman C, Zureik M, Chouaid C, Vergnenegre A, Huchon G, et al. Chronic bronchitis in the general population: influence of age, gender and socio-economic conditions. Respir Med. 2012;106(3):467–71.CrossRefPubMedGoogle Scholar
  42. 42.
    Kanervisto M, Vasankari T, Laitinen T, Heliovaara M, Jousilahti P, Saarelainen S. Low socioeconomic status is associated with chronic obstructive airway diseases. Respir Med. 2011;105(8):1140–6.CrossRefPubMedGoogle Scholar
  43. 43.
    Yin P, Zhang M, Li Y, Jiang Y, Zhao W. Prevalence of COPD and its association with socioeconomic status in China: findings from China Chronic Disease Risk Factor Surveillance 2007. BMC Public Health. 2011;11:586.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Danielsson P, Olafsdottir IS, Benediktsdottir B, Gislason T, Janson C. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden—the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study. Clin Respir J. 2012;6(2):120–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Miriam Siegel
    • 1
  • Jerry A. Krishnan
    • 2
  • Jamie Lamson-Sullivan
    • 3
  • Scott Cerreta
    • 3
  • David M. Mannino
    • 1
  1. 1.Department of Preventive Medicine and Environmental HealthUniversity of Kentucky College of Public HealthLexingtonUSA
  2. 2.Breathe Chicago Center, Division of Pulmonary, Critical Care, Sleep & AllergyUniversity of Illinois in ChicagoChicagoUSA
  3. 3.The COPD FoundationWashington, DCUSA

Personalised recommendations